A9847
Angiopoietin-2 human
>97% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder
Synonym(s):
Ang-2
Sign Into View Organizational & Contract Pricing
Select a Size
1 EA
CN¥5,326.80
CN¥5,326.80
Please contact Customer Service for Availability
All Photos(1)
Select a Size
Change View
1 EA
CN¥5,326.80
About This Item
CN¥5,326.80
Please contact Customer Service for Availability
Recommended Products
biological source
human
Quality Level
recombinant
expressed in NSO cells
Assay
>97% (SDS-PAGE)
form
lyophilized powder
mol wt
66 kDa by SDS-PAGE (reducing and non-reducing conditions)
66 kDa by SDS-PAGE
packaging
pkg of 25 μg
storage condition
avoid repeated freeze/thaw cycles (Do not store in a frost-free freezer.)
impurities
endotoxin, tested
UniProt accession no.
Biochem/physiol Actions
This ligand is a naturally occurring inhibitor of angiopoietin-1 and Tie-2 both in vivo and in vitro, and has important roles in embryogenic angiogenesis and maintaining the integrity of adult vasculature.
Physical form
Lyophilized from a 0.2 μm filtered solution in 20 mM MOPS, 500 mM NaCl, 0.1% PEG-8000, 0.2% CHAPS, pH 7.0 containing 50 μg bovine serum albumin per 1 μg of cytokine.
Analysis Note
The biological activity is measured a competitive binding assay.
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Information
新产品
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
B Witzenbichler et al.
The Journal of biological chemistry, 273(29), 18514-18521 (1998-07-11)
Angiopoietin-1 and its putative natural antagonist, angiopoietin-2, were recently isolated, and the critical role of angiopoietin-1 in embryogenic angiogenesis was demonstrated by targeted gene disruption. Specific biological effects of angiopoietin-1, however, have yet to be defined. In this study we
Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1.
Yang, et al.
Cell Death & Disease, 14, 344-344 (2023)
Hsiu-Mei Chen et al.
Oncotarget, 6(17), 14940-14952 (2015-04-25)
Foretinib, a multiple kinase inhibitor undergoing clinical trials, could suppress the activity of hepatocyte growth factor (HGF) receptor c-MET and vascular endothelial growth factor receptor-2 (VEGFR-2). In addition, Foretinib may inhibit two critical lymphangiogenic signaling receptors VEGFR-3 and TIE-2. However
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
